Atlas Trials

A Real-World Study Evaluating the Efficacy and Safety of Adebrelimab in Patients With Advanced SCLC

Clinical trial NCT07434518 · RECRUITING

Trial details

NCT number
NCT07434518
Sponsor
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Status
RECRUITING
Study type
OBSERVATIONAL
Small Cell Lung Cancer (SCLC)
Start date
2026-01-27
Primary completion
2027-12-31
Enrollment
500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.